
By Ajay Makan in New York More than $1bn was wiped off the market capitalisation of pharmaceutical company Hospira on Tuesday, after the firm said a Food and Drug Administration investigation is affecting output from its main manufacturing plant. ... Hospira hit by production disruption
No comments:
Post a Comment